Search research articles
Contact Us
Filters
Showing results (361-370 of 381) with videos related to
Page
of 39
Sort By:
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol
E Bernichon, A Vallard, Q Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial
Thomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies
Orit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
The Lancet. Oncology
|
November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
Philip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial
Yungan Tao, Anne Auperin, Christian Sire, et al.
Blood
|
May 13, 2006
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin
Bernard Tardy, Thomas Lecompte, Françoise Boelhen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925
Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 18, 2021
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors
Nicolas Meillan, Alexandre Orthuon, Paul Chauchat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 381) with videos related to
Sort By:
Page
of 39
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol
E Bernichon, A Vallard, Q Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial
Thomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies
Orit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
The Lancet. Oncology
|
November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
Philip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial
Yungan Tao, Anne Auperin, Christian Sire, et al.
Blood
|
May 13, 2006
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin
Bernard Tardy, Thomas Lecompte, Françoise Boelhen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925
Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 18, 2021
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors
Nicolas Meillan, Alexandre Orthuon, Paul Chauchat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
Page
of 39